Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP328040.RAqifcbBO2g6HU9ec0JbvbDZ0LCs7e7_mfBvmUkDwn2i4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP328040.RAqifcbBO2g6HU9ec0JbvbDZ0LCs7e7_mfBvmUkDwn2i4130_assertion type Assertion NP328040.RAqifcbBO2g6HU9ec0JbvbDZ0LCs7e7_mfBvmUkDwn2i4130_head.
- NP328040.RAqifcbBO2g6HU9ec0JbvbDZ0LCs7e7_mfBvmUkDwn2i4130_assertion description "[In 50 cases (62%), the percentage of SPF agreed approximately in primary tumors and in the correspondent metastases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP328040.RAqifcbBO2g6HU9ec0JbvbDZ0LCs7e7_mfBvmUkDwn2i4130_provenance.
- NP328040.RAqifcbBO2g6HU9ec0JbvbDZ0LCs7e7_mfBvmUkDwn2i4130_assertion evidence source_evidence_literature NP328040.RAqifcbBO2g6HU9ec0JbvbDZ0LCs7e7_mfBvmUkDwn2i4130_provenance.
- NP328040.RAqifcbBO2g6HU9ec0JbvbDZ0LCs7e7_mfBvmUkDwn2i4130_assertion SIO_000772 2706325 NP328040.RAqifcbBO2g6HU9ec0JbvbDZ0LCs7e7_mfBvmUkDwn2i4130_provenance.
- NP328040.RAqifcbBO2g6HU9ec0JbvbDZ0LCs7e7_mfBvmUkDwn2i4130_assertion wasDerivedFrom befree-20140225 NP328040.RAqifcbBO2g6HU9ec0JbvbDZ0LCs7e7_mfBvmUkDwn2i4130_provenance.
- NP328040.RAqifcbBO2g6HU9ec0JbvbDZ0LCs7e7_mfBvmUkDwn2i4130_assertion wasGeneratedBy ECO_0000203 NP328040.RAqifcbBO2g6HU9ec0JbvbDZ0LCs7e7_mfBvmUkDwn2i4130_provenance.